Skip to main navigation Skip to search Skip to main content

Breast cancer screening and diagnosis: A synopsis of the european breast guidelines

  • Holger J. Schünemann
  • , Donata Lerda
  • , Cecily Quinn
  • , Markus Follmann
  • , Pablo Alonso-Coello
  • , Paolo Giorgi Rossi
  • , Annette Lebeau
  • , Lennarth Nyström
  • , Mireille Broeders
  • , Lydia Ioannidou-Mouzaka
  • , Stephen W. Duffy
  • , Bettina Borisch
  • , Patricia Fitzpatrick
  • , Solveig Hofvind
  • , Xavier Castells
  • , Livia Giordano
  • , Carlos Canelo-Aybar
  • , Sue Warman
  • , Robert Mansel
  • , Francesco Sardanelli
  • Elena Parmelli, Axel Gräwingholt, Zuleika Saz-Parkinson
  • European Commission
  • University College Dublin
  • German Cancer Society
  • Centro de Investigación Biomédicaen Red de Epidemiología y Salud Pública (CIBERESP)
  • IRCCS Azienda Unità Sanitaria Locale di Reggio Emilia
  • University of Hamburg
  • Umeå University
  • Radboud University Nijmegen
  • Leto Gynecological-Surgical and Obstetrical Clinic
  • Queen Mary University of London
  • University of Geneva
  • National Screening Service
  • Cancer Registry of Norway Institute of Population-Based Cancer Research
  • Hospital del Mar
  • CPO-Piedmont - AOU Citta` della Salute e della Scienza
  • Havyatt Lodge
  • Cardiff University
  • University of Milan
  • Radiologie am Theater

Research output: Contribution to journalArticlepeer-review

251 Scopus citations

Abstract

Description: The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health professionals, and policymakers. Methods: An international guideline panel of 28 multidisciplinary members, including patients, developed questions and corresponding recommendations that were informed by systematic reviews of the evidence conducted between March 2016 and December 2018. GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests by enhancing transparency. Questions and recommendations, expressed as strong or conditional, focused on outcomes that matter to women and provided a rating of the certainty of evidence. Recommendations: This synopsis of the European Breast Guidelines provides recommendations regarding organized screening programs for women aged 40 to 75 years who are at average risk. The recommendations address digital mammography screening and the addition of hand-held ultrasonography, automated breast ultrasonography, or magnetic resonance imaging compared with mammography alone. The recommendations also discuss the frequency of screening and inform decision making for women at average risk who are recalled for suspicious lesions or who have high breast density.

Original languageEnglish
Pages (from-to)46-56
Number of pages11
JournalAnnals of Internal Medicine
Volume172
Issue number1
DOIs
StatePublished - Jan 7 2020

Fingerprint

Dive into the research topics of 'Breast cancer screening and diagnosis: A synopsis of the european breast guidelines'. Together they form a unique fingerprint.

Cite this